Final Reflections and Future Directions

In the closing segment the faculty reflect on polycythemia vera as a field undergoing meaningful change. Emerging therapies offer opportunities to reduce treatment burden, improve symptom control, and enhance quality of life. The panel reiterates that future progress will depend on maintaining focus on patient experience alongside traditional hematologic goals. Continued research, collaboration between academic and community clinicians, and thoughtful integration of new therapies are identified as key priorities. The discussion concludes with cautious optimism that advances in iron regulation, cytoreduction, and molecular understanding will collectively improve long term outcomes for patients living with PV.